101 related articles for article (PubMed ID: 21906454)
1. [Clinical analysis of anti glomerular basement membrane disease with normal renal function].
Mou LJ; Chen LM; Zuo LM; Wang HY; Tao JL; Wen YB; Ye W-; Qin Y; Li H; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Aug; 33(4):432-5. PubMed ID: 21906454
[TBL] [Abstract][Full Text] [Related]
2. [A clinical and pathological analysis of 41 patients with anti-glomerular basement membrane antibody related diseases].
Zhao M; Ding J; Liu Y; Zou W; Wang H
Zhonghua Nei Ke Za Zhi; 2001 May; 40(5):316-20. PubMed ID: 11798594
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and prognosis of Chinese patients with anti-glomerular basement membrane disease.
Cui Z; Zhao MH; Xin G; Wang HY
Nephron Clin Pract; 2005; 99(2):c49-55. PubMed ID: 15637429
[TBL] [Abstract][Full Text] [Related]
4. Anti-glomerular basement membrane (GBM)-antibody-mediated disease with normal renal function.
Ang C; Savige J; Dawborn J; Miach P; Heale W; Clarke B; Sinclair RS
Nephrol Dial Transplant; 1998 Apr; 13(4):935-9. PubMed ID: 9568853
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and outcomes of anti-glomerular basement membrane disease in older patients.
Cui Z; Zhao J; Jia XY; Zhu SN; Zhao MH
Am J Kidney Dis; 2011 Apr; 57(4):575-82. PubMed ID: 21168945
[TBL] [Abstract][Full Text] [Related]
6. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
[TBL] [Abstract][Full Text] [Related]
7. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome.
Walker RG; Scheinkestel C; Becker GJ; Owen JE; Dowling JP; Kincaid-Smith P
Q J Med; 1985 Jan; 54(213):75-89. PubMed ID: 3975346
[TBL] [Abstract][Full Text] [Related]
8. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease.
Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features and outcome of antibody-negative anti-glomerular basement membrane disease.
Liang D; Liang S; Xu F; Zhang M; Li X; Tu Y; Liu Z; Zeng C
J Clin Pathol; 2019 Jan; 72(1):31-37. PubMed ID: 30315136
[TBL] [Abstract][Full Text] [Related]
10. Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases.
Merkel F; Pullig O; Marx M; Netzer KO; Weber M
Nephrol Dial Transplant; 1994; 9(4):372-6. PubMed ID: 8084449
[TBL] [Abstract][Full Text] [Related]
11. Anti-GBM disease: predictive value of clinical, histological and serological data.
Herody M; Bobrie G; Gouarin C; Grünfeld JP; Noel LH
Clin Nephrol; 1993 Nov; 40(5):249-55. PubMed ID: 8281713
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
[TBL] [Abstract][Full Text] [Related]
13. Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group.
Chauveau B; Gibier JB; Olagne J; Morel A; Aydin S; McAdoo SP; Viallet N; Perrochia H; Pambrun E; Royal V; Demoulin N; Kemeny JL; Philipponnet C; Hertig A; Boffa JJ; Plaisier E; Domenger C; Brochériou I; Deltombe C; Duong Van Huyen JP; Buob D; Roufosse C; Hellmark T; Audard V; Mihout F; Nasr SH; Renaudin K; Moktefi A; Rabant M;
Am J Kidney Dis; 2024 Jun; 83(6):713-728.e1. PubMed ID: 38171412
[TBL] [Abstract][Full Text] [Related]
14. [Avidity of anti-glomerular basement membrane autoantibodies was associated with renal pathological damage].
Cui Z; Zhao MH
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):903-7. PubMed ID: 16029529
[TBL] [Abstract][Full Text] [Related]
15. Serum BAFF and APRIL might be associated with disease activity and kidney damage in patients with anti-glomerular basement membrane disease.
Xin G; Cui Z; Su Y; Xu LX; Zhao MH; Li KS
Nephrology (Carlton); 2013 Mar; 18(3):209-14. PubMed ID: 23317407
[TBL] [Abstract][Full Text] [Related]
16. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity.
Cui Z; Zhao MH
Clin Immunol; 2005 Jul; 116(1):77-82. PubMed ID: 15925834
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis.
Nasr SH; Collins AB; Alexander MP; Schraith DF; Herrera Hernandez L; Fidler ME; Sethi S; Leung N; Fervenza FC; Cornell LD
Kidney Int; 2016 Apr; 89(4):897-908. PubMed ID: 26994577
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics and predictors of poor outcome in anti-glomerular basement membrane disease - a fifteen year single center experience.
Zahir Z; Wani AS; Prasad N; Jain M
Ren Fail; 2021 Dec; 43(1):79-89. PubMed ID: 33334228
[TBL] [Abstract][Full Text] [Related]
19. Anti-glomerular basement membrane antibodies.
Silvariño R; Noboa O; Cervera R
Isr Med Assoc J; 2014 Nov; 16(11):727-32. PubMed ID: 25558706
[TBL] [Abstract][Full Text] [Related]
20. Clinical-Pathological Features and Outcome of Atypical Anti-glomerular Basement Membrane Disease in a Large Single Cohort.
Shen CR; Jia XY; Cui Z; Yu XJ; Zhao MH
Front Immunol; 2020; 11():2035. PubMed ID: 33013861
[No Abstract] [Full Text] [Related]
[Next] [New Search]
